WHO ICTRP trial
Clinical observation of Liushen Pill in treatment of COVID-19 long-term positive…
ChiCTR2200057532 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200057532 |
|---|---|
| Public title | Clinical observation of Liushen Pill in treatment of COVID-19 long-term positive patients |
| Scientific title | Clinical observation of Liushen Pill in treatment of COVID-19 long-term positive patients |
| Primary sponsor | The Fifth People's Hospital of Suzhou |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Novel Coronavirus Pneumonia (COVID-19) |
| Interventions | experimental group:Liushen pill and basic treatment;control group:basic treatment |
| Registration date | Mar 14, 2022 |
| Target size | experimental group:40;control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: